July 20, 2017
Bioanalysis Zone launches The Expert Series of Webinars
Bioanalysis Zone and the University of Wisconsin-Madison’s School of Pharmacy are partnering on a new collection informative webinars on hot topic areas relevant to bioanalytical scientists: The Expert Series.
This Series will help bioanalysts to enhance their knowledge and encourage an open dialog among the bioanalytical community.
Erik Burns, Chair of the Division of Pharmacy Professional Development, commented: “The Division of Pharmacy Professional Development at UW-Madison’s School of Pharmacy, in partnership with Bioanalysis Zone, each hold a desire to produce and distribute application-based and focused webinars that are valid, commercial free and impactful to the bioanalytical scientist anywhere in the world through leading-edge content and technology.”
Sarah Mayes, Publisher of Bioanalysis Zone, remarked: “We are very excited about this new partnership; we see it as a fantastic way to support the career development of scientists around the world. By providing free access to these webinars, experts can impart their knowledge and questions can be asked in an educational setting.”
The series launches with Adam Hill, CEO of Prospective Research (MA, USA), speaking about ‘Changes and challenges in early drug discovery today’. Registration is open so you can join this webinar by visiting: https://www.bioanalysis-zone.com/2017/06/30/expert-series-adam-hill/
To keep up-to-date with the latest news on The Expert Series and to find further instructions on how to watch the webinars live, follow @BioanalysisZone on Twitter using the #BZexpertseries, and sign up to Bioanalysis Zone for free at www.bioanalysis-zone.com
About Bioanalysis Zone
Since launching in 2011, Bioanalysis Zone has attracted over 6,000 active members from the global bioanalytical community, representing the pharmaceutical, biotech and CRO industries, along with academia and healthcare. Each month, thousands of members visit the site to read industry news, original research exclusive interviews and commentaries.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG’s portfolio includes two imprints: Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.